SCHEMBL3636050

SCHEMBL3636050

N#Cc1ccccc1S(=O)(=O)N1CCCCC1COCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.48
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
MCOLN3 Q8TDD5 1/20 0.43
KDM4E B2RXH2 2/20 0.41
PKM P14618 1/20 0.41
AKR1C3 P42330 1/20 0.39
HTR7 P34969 3/20 0.38
HTR1D P28221 2/20 0.38
HTR2B P41595 2/20 0.38
HTR1A P08908 1/20 0.38
DRD2 P14416 1/20 0.38
DRD3 P35462 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRK1 P41145 1/20 0.38
CASP3 P42574 3/20 0.38
CASP1 P29466 2/20 0.38
CASP7 P55210 2/20 0.38
CASP6 P55212 2/20 0.38
CTDSP1 Q9GZU7 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14048027 0.85 ALDH1A1 (0.44) ALDH1A1KMT2AMCOLN3HTR7HTR1D
SCHEMBL5132145 0.83 HTR7 (0.57) ALDH1A1KMT2AMCOLN3HTR7HTR1D
SCHEMBL3441492 0.82 HCRTR1 (0.48) ALDH1A1KMT2AMCOLN3OPRM1OPRK1
SCHEMBL699933 0.82 HCRTR1 (0.48) ALDH1A1KMT2AMCOLN3OPRM1OPRK1
SCHEMBL3634695 0.81 TSHR (0.47) ALDH1A1KMT2AMCOLN3AKR1C3HTR7
SCHEMBL2564263 0.78 BDKRB1 (0.48) ALDH1A1KMT2AMCOLN3KDM4EHTR7
SCHEMBL5132594 0.77 ATM (0.46) ATMCASP3CASP7TDP1
SCHEMBL5093730 0.76 PSEN1 (0.62) ALDH1A1KMT2ACASP3CASP7
SCHEMBL2569069 0.76 FKBP1A (0.48) ALDH1A1CASP3CASP1CASP7CASP6
SCHEMBL4537339 0.75 ATM (0.49) ATMALDH1A1KMT2AMCOLN3OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155678-A1 NEW BRADYKININ B1 ANTAGONISTS EVOTEC Neurosciences GmbH (DE) 2010-02-24 EP disclosed
WO-2008125570-A1 NEW BRADYKININ B1 ANTAGONISTS EVOTEC NEUROSCIENCES GMBH (DE) 2008-10-23 WO disclosed